Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASP0456 (Linzess) in Chronic Constipation
NCT02809105Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Jun 2016
- Primary completion
- Nov 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of linaclotide in chronic constipation, sponsored by Astellas Pharma. Started Jun 2016; status: completed.
02
Drugs
linaclotide
03
Conditions
chronic constipation
Beyond the preview
Go deeper on NCT02809105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02809105.